AR021485A1 - Genes reguladores de streptomyces avermitilis para produccion aumentada de avermectinas. - Google Patents

Genes reguladores de streptomyces avermitilis para produccion aumentada de avermectinas.

Info

Publication number
AR021485A1
AR021485A1 ARP990104584A ARP990104584A AR021485A1 AR 021485 A1 AR021485 A1 AR 021485A1 AR P990104584 A ARP990104584 A AR P990104584A AR P990104584 A ARP990104584 A AR P990104584A AR 021485 A1 AR021485 A1 AR 021485A1
Authority
AR
Argentina
Prior art keywords
avermectins
genes
avermectines
streptomyces avermitilis
increased production
Prior art date
Application number
ARP990104584A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR021485A1 publication Critical patent/AR021485A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El presente invento está dirigido a composiciones y métodos para producir avermectinas, y está situado principalmente en el sector de la salud de losanimales. El presente invento se refiere a la identificacion y la caracterizacion de dos nuevos genes, aquí citados como los genes aveR1 y aveR2, queestán implicados en regular la expresion de policetida-sintasa (PKS) de avermectinas y la biosíntesis de avermectinas en Streptomyces avermitilis. Elpresente invento está basado en el descubrimiento deque la desactivacion de estos genes da como resultado un aumento en la cantidad de avermectinasproducidas por S.avermitilis.
ARP990104584A 1998-09-14 1999-09-13 Genes reguladores de streptomyces avermitilis para produccion aumentada de avermectinas. AR021485A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10013498P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
AR021485A1 true AR021485A1 (es) 2002-07-24

Family

ID=22278261

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104584A AR021485A1 (es) 1998-09-14 1999-09-13 Genes reguladores de streptomyces avermitilis para produccion aumentada de avermectinas.

Country Status (17)

Country Link
US (2) US6197591B1 (es)
EP (1) EP0997528A1 (es)
JP (1) JP3595210B2 (es)
KR (1) KR100343357B1 (es)
CN (1) CN1252440A (es)
AR (1) AR021485A1 (es)
AU (1) AU758329B2 (es)
BR (1) BR9904109A (es)
CA (1) CA2281935A1 (es)
HU (1) HUP9903073A3 (es)
ID (1) ID23542A (es)
IL (1) IL131845A0 (es)
IN (1) IN190976B (es)
PL (1) PL335438A1 (es)
RU (1) RU2221042C2 (es)
TR (1) TR199902239A2 (es)
ZA (1) ZA995872B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720415B2 (en) * 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
CA2402398A1 (en) * 2000-02-24 2001-08-30 Kyowa Hakko Kogyo Co., Ltd. Process for producing avermectin derivative
JP2003532698A (ja) 2000-05-10 2003-11-05 プリンストン ユニバーシティ 細菌の増殖および病理発生を調節するための化合物ならびに方法
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
ES2321827T3 (es) * 2002-02-12 2009-06-12 Pfizer Products Inc. Gen de streptomyces avermitilis que rige la relacion de avermectinas b2-b1.
US7326782B2 (en) * 2003-08-21 2008-02-05 Wisconsin Alumni Research Foundation Metabolic engineering of viomycin biosynthesis
US7645600B2 (en) * 2004-07-23 2010-01-12 Shin-Etsu Chemical Co., Ltd. Compositions and methods for enhanced bacterial exopolysaccharide production
KR100564156B1 (ko) * 2004-08-23 2006-03-24 주식회사 진켐 스트렙토마이세스 푸세티우스 유래 전사활성체 및 그 유전자
JP2006296419A (ja) * 2005-03-04 2006-11-02 Hiroshima Univ 遺伝子破壊による抗生物質産生微生物の生産方法およびこれを用いて得られる抗生物質産生微生物、並びに抗生物質代謝中間体の生産方法
BRPI0809361A2 (pt) * 2007-03-30 2014-09-02 Abbott Lab Elementos de vetor de expressão recombinante (reves) para melhorar a expressão de proteínas recombinantes em células hospedeiras

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362816A (en) 1980-11-13 1982-12-07 The Upjohn Company Hybrid plasmid and process of making same
US4898828A (en) 1985-08-07 1990-02-06 Eli Lilly And Company Ultrahigh copy number streptomycetes plasmids
US5242809A (en) 1986-02-28 1993-09-07 Smithkline Beecham Corporation Gal operon of streptomyces
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
EP0313297B1 (en) 1987-10-23 1993-05-19 Pfizer Inc. Process for production of avermectin aglycones and cultures therefor
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
US5264354A (en) 1988-09-30 1993-11-23 Eli Lilly And Company Method for isolating transposable elements from streptomyces
EP0391594B1 (en) 1989-03-31 1995-10-18 Merck & Co. Inc. Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
US5122595A (en) 1989-05-19 1992-06-16 Applied Research Systems Ars Holding N.V. SAF polypeptide gene coding therefor, and SAF promoter
US5118617A (en) 1989-05-19 1992-06-02 Applied Research Systems Ars Holding N.V. Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces
ES2204914T3 (es) 1993-07-30 2004-05-01 Pfizer Inc. Genes que codifican el complejo alfa cetoacido deshidrogenasa de cadena ramificada de streptomyces avermitilis.
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US5474912A (en) 1994-03-03 1995-12-12 Sherman; David H. Method for increasing production of microbial metabolites by genetic engineering
US5876987A (en) 1996-02-07 1999-03-02 Board Of Trustees Operating Michigan State University Method, DNA and bacteria for hyperproduction of an antibiotic due to disruption of an AbsA gene

Also Published As

Publication number Publication date
HUP9903073A3 (en) 2005-05-30
US6197591B1 (en) 2001-03-06
HU9903073D0 (en) 1999-11-29
IN190976B (es) 2003-09-06
CN1252440A (zh) 2000-05-10
JP2000102394A (ja) 2000-04-11
RU2221042C2 (ru) 2004-01-10
ZA995872B (en) 2001-03-13
HUP9903073A2 (en) 2000-07-28
EP0997528A1 (en) 2000-05-03
US6689611B1 (en) 2004-02-10
KR20000023111A (ko) 2000-04-25
AU758329B2 (en) 2003-03-20
TR199902239A2 (xx) 2000-04-21
ID23542A (id) 2000-05-04
PL335438A1 (en) 2000-03-27
AU4757599A (en) 2000-03-23
CA2281935A1 (en) 2000-03-14
IL131845A0 (en) 2001-03-19
KR100343357B1 (ko) 2002-07-15
BR9904109A (pt) 2000-10-17
JP3595210B2 (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
AR021485A1 (es) Genes reguladores de streptomyces avermitilis para produccion aumentada de avermectinas.
Shah et al. Recent advancement of engineering microbial hosts for the biotechnological production of flavonoids
Stefanska et al. Epigenetic mechanisms in anti‐cancer actions of bioactive food components–the implications in cancer prevention
Qiu et al. Kaempferol modulates DNA methylation and downregulates DNMT3B in bladder cancer
Ikeda et al. Avermectin biosynthesis
Kanwal et al. Dietary flavones as dual inhibitors of DNA methyltransferases and histone methyltransferases
SG165394A1 (en) Modulation of immunostimulatory properties of short interfering ribonucleic acid (sirna) by nucleotide modification
WO2018191278A3 (en) Targeted compositions
WO2003064621A3 (en) HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
GB2397818A (en) Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
CL2021002585A1 (es) Composiciones y métodos para inhibir la expresión génica en el sistema nervioso central
GT200100159A (es) Antibioticos macrolidos
GT200500008A (es) Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
GT200200066A (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
ATE525469T1 (de) Nachweis kleiner nukleinsäuren
WO2005044981A3 (en) Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
WO2005002507A3 (en) Modulation of survivin expression
GT200300292A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
Koirala et al. Metabolic engineering of Escherichia coli for the production of isoflavonoid‐4′‐O‐methoxides and their biological activities
Kutty et al. Revealing floral metabolite network in tuberose that underpins scent volatiles synthesis, storage and emission
BR0309766A (pt) Promotores usp semente especìficos para expressar genes em vegetais
BR0311142A (pt) Processos para produzir por fermentação pelo menos um produto quìmico fino contendo enxofre, e para produzir um aditivo de ração animal contendo l-metionina a partir de caldos de fermentação, polinucleotìdeos isolado, mutante de metk com atividade reduzida, bactéria corineiforme recombinante, e, construção de expressão
AR050866A1 (es) Genes de inositol polifosfato 2-quinasa y usos de los mismos
WO2005045032A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal